Any feedback?
Literature summary extracted from
- Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine (2000), Mol. Pharmacol., 58, 1326-1332.
Cloned(Commentary)
| EC Number | Cloned (Comment) | Organism |
|---|---|---|
| 2.7.1.21 | - |
Herpes simplex virus |
Protein Variants
| EC Number | Protein Variants | Comment | Organism |
|---|---|---|---|
| 2.7.1.21 | A167Y | heavily reduced ability to phosphorylate pyrimidine nucleosides, ability to phosphorylate ganciclovir and lobucavir is reduced 2fold | Herpes simplex virus |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 2.7.1.21 | Herpes simplex virus | - |
type 1 | - |
Purification (Commentary)
| EC Number | Purification (Comment) | Organism |
|---|---|---|
| 2.7.1.21 | wild-type and A167Y mutant | Herpes simplex virus |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 2.7.1.21 | ATP + ganciclovir | - |
Herpes simplex virus | ? | - |
? |  |
| 2.7.1.21 | ATP + lobucavir | - |
Herpes simplex virus | ? | - |
? | |
| 2.7.1.21 | ATP + thymidine | - |
Herpes simplex virus | ADP + dTMP | - |
? | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
